ITRM vs LOW · rev $390.0K vs P/E 18, rev $86.29B
Iterum Therapeutics PLC (ITRM) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
ITRM currently screens at market cap $38.6M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the ITRM and LOW stock pages for the full models.
Not investment advice.